Top Markets
Coin of the day
Cambium Bio Limited Cambium Bio Limited

Cambium Bio Limited

CMB
Rank in Stocks #33320
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Share Price
$0.26800822
Market Cap
$7.89M
Change (1 day)
5.56%
Change (1 year)
11.35%
Country
AU
Trade Cambium Bio Limited (CMB)

Category

Stock split history for Cambium Bio Limited (CMB)
Cambium Bio Limited stock (symbol: CMB) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 17, 2026.
One CMB share bought prior to Aug 17, 2026 would equal to 0 CMB shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE